2013 annual financial data
Aytu BioPharma 2013 Net margin
Direct answer
Net margin was -3,275.31%.
Operating income was -52,414 USD and net income was -57,318 USD.
Operating cash flow was -37,704 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,750 USD
- Operating income
- -52,414 USD
- Net income
- -57,318 USD
- Operating cash flow
- -37,704 USD